These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 34643417)

  • 1. Early Prediction of Severe COVID-19 in Patients by a Novel Immune-Related Predictive Model.
    Sun C; Xue M; Yang M; Zhu L; Zhao Y; Lv X; Lin Y; Ma D; Shen X; Cheng Y; Xuan H; Jia X; Li T; Han L
    mSphere; 2021 Oct; 6(5):e0075221. PubMed ID: 34643417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk stratification scores for hospitalization duration and disease progression in moderate and severe patients with COVID-19.
    Huang J; Xu Y; Wang B; Xiang Y; Wu N; Zhang W; Xia T; Yuan Z; Li C; Jia X; Shan Y; Chen M; Li Q; Bai L; Li Y
    BMC Pulm Med; 2021 Apr; 21(1):120. PubMed ID: 33853568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which hematological markers have predictive value as early indicators of severe COVID-19 cases in the emergency department?
    Şan İ; Gemcioğlu E; Davutoğlu M; Çatalbaş R; Karabuğa B; Kaptan E; Erden A; Küçükşahin O; Ateş İ; Karaahmetoğlu S; Hasanoğlu İ; İnan O; Ünal BN; Erdemir E; Kahraman FA; Güner R
    Turk J Med Sci; 2021 Dec; 51(6):2810-2821. PubMed ID: 33726485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavior of Eosinophil Counts in Recovered and Deceased COVID-19 Patients over the Course of the Disease.
    Cortés-Vieyra R; Gutiérrez-Castellanos S; Álvarez-Aguilar C; Baizabal-Aguirre VM; Nuñez-Anita RE; Rocha-López AG; Gómez-García A
    Viruses; 2021 Aug; 13(9):. PubMed ID: 34578258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features predicting mortality risk in older patients with COVID-19.
    Zhou J; Huang L; Chen J; Yuan X; Shen Q; Dong S; Cheng B; Guo TM
    Curr Med Res Opin; 2020 Nov; 36(11):1753-1759. PubMed ID: 32945707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying COVID-19 cases in outpatient settings.
    Mao Y; Tan YR; Thein TL; Chai YAL; Cook AR; Dickens BL; Lew YJ; Lim FS; Lim JT; Sun Y; Sundaram M; Soh A; Tan GSE; Wong FPG; Young B; Zeng K; Chen M; Ong DLS
    Epidemiol Infect; 2021 Apr; 149():e92. PubMed ID: 33814027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of biological markers in the early prediction of corona virus disease-2019 severity.
    Bennouar S; Bachir Cherif A; Kessira A; Hamel H; Boudahdir A; Bouamra A; Bennouar D; Abdi S
    Scand J Clin Lab Invest; 2020 Dec; 80(8):611-618. PubMed ID: 32945705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel serological biomarkers for inflammation in predicting disease severity in patients with COVID-19.
    Xue G; Gan X; Wu Z; Xie D; Xiong Y; Hua L; Zhou B; Zhou N; Xiang J; Li J
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107065. PubMed ID: 33045571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of the neutrophil to lymphocyte ratio for disease deterioration and serious adverse outcomes in patients with COVID-19: a prospective cohort study.
    Zeng ZY; Feng SD; Chen GP; Wu JN
    BMC Infect Dis; 2021 Jan; 21(1):80. PubMed ID: 33461497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinopenia <100/μL as a marker of active COVID-19: An observational prospective study.
    Outh R; Boutin C; Gueudet P; Suzuki M; Saada M; Aumaître H
    J Microbiol Immunol Infect; 2021 Feb; 54(1):61-68. PubMed ID: 33468435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comprehensive Appraisal of Laboratory Biochemistry Tests as Major Predictors of COVID-19 Severity.
    Aloisio E; Chibireva M; Serafini L; Pasqualetti S; Falvella FS; Dolci A; Panteghini M
    Arch Pathol Lab Med; 2020 Dec; 144(12):1457-1464. PubMed ID: 32649222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severity of COVID-19 Respiratory Complications during Pregnancy are Associated with Degree of Lymphopenia and Neutrophil to Lymphocyte Ratio on Presentation: A Multicenter Cohort Study.
    Lasser DM; Chervenak J; Moore RM; Li T; Knight C; Teo HO; Malhotra Y;
    Am J Perinatol; 2021 Oct; 38(12):1236-1243. PubMed ID: 34396499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and roles of severe acute respiratory syndrome coronavirus 2-specific antibodies in patients with different severities of coronavirus 19.
    Huang Z; Chen H; Xue M; Huang H; Zheng P; Luo W; Liang X; Sun B; Zhong N
    Clin Exp Immunol; 2020 Nov; 202(2):210-219. PubMed ID: 32706417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies.
    Tré-Hardy M; Wilmet A; Beukinga I; Favresse J; Dogné JM; Douxfils J; Blairon L
    J Med Virol; 2021 Feb; 93(2):803-811. PubMed ID: 32667733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study.
    Zheng Y; Zhang Y; Chi H; Chen S; Peng M; Luo L; Chen L; Li J; Shen B; Wang D
    Clin Chem Lab Med; 2020 Jun; 58(7):1106-1115. PubMed ID: 32352397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical value of laboratory indicators for predicting disease progression and death in patients with COVID-19: a retrospective cohort study.
    Wang Q; Cheng J; Shang J; Wang Y; Wan J; Yan YQ; Liu WB; Zhang HP; Wang JP; Wang XY; Li ZA; Lin J
    BMJ Open; 2021 Oct; 11(10):e043790. PubMed ID: 34598979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count.
    Bi X; Su Z; Yan H; Du J; Wang J; Chen L; Peng M; Chen S; Shen B; Li J
    Platelets; 2020 Jul; 31(5):674-679. PubMed ID: 32367765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-6-based mortality risk model for hospitalized patients with COVID-19.
    Laguna-Goya R; Utrero-Rico A; Talayero P; Lasa-Lazaro M; Ramirez-Fernandez A; Naranjo L; Segura-Tudela A; Cabrera-Marante O; Rodriguez de Frias E; Garcia-Garcia R; Fernández-Ruiz M; Aguado JM; Martinez-Lopez J; Lopez EA; Catalan M; Serrano A; Paz-Artal E
    J Allergy Clin Immunol; 2020 Oct; 146(4):799-807.e9. PubMed ID: 32710975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of eosinopenia as a diagnostic and prognostic indicator in COVID-19 infection.
    Soni M
    Int J Lab Hematol; 2021 Jul; 43 Suppl 1():137-141. PubMed ID: 33289964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative Stress and Inflammatory Biomarkers for the Prediction of Severity and ICU Admission in Unselected Patients Hospitalized with COVID-19.
    Ducastel M; Chenevier-Gobeaux C; Ballaa Y; Meritet JF; Brack M; Chapuis N; Pene F; Carlier N; Szwebel TA; Roche N; Terrier B; Borderie D
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.